Try our Advanced Search for more refined results

Erin Hexum et al v. Eli Lilly and Company et al

  1. August 13, 2015

    Judge Cuts 2nd Cymbalta Trial Short With Verdict For Lilly

    Eli Lilly & Co. on Thursday defeated claims that it concealed the withdrawal risks of its antidepressant Cymbalta when a California federal judge cut short a trial and issued a directed verdict for the drugmaker, less than a week after jurors in another California suit cleared the company.

  2. August 11, 2015

    Eli Lilly Faces Second Cymbalta Trial After Bellwether Win

    Days after Eli Lilly & Co. defeated claims it concealed the withdrawal risks of its antidepressant Cymbalta in a bellwether trial, the company found itself facing off against the same attorneys in a California federal courtroom as the trial of a second Cymbalta user opened.

  3. August 11, 2015

    Eli Lilly Gets Expert Testimony Narrowed In Cymbalta Suit

    A California federal judge ruled Monday that a woman accusing Eli Lilly & Co. of concealing the sleep drug Cymbalta's withdrawal risks can't rely on a clinical psychiatrist's testimony that the company buried an article on those risks in an "obscure" Dutch medical journal.

  4. August 05, 2015

    Eli Lilly Slams Cymbalta Plaintiff Ahead Of Trial

    Eli Lilly & Co. fired back Tuesday at a California woman who accused the drugmaker of vastly understating the alleged withdrawal risks of its antidepressant Cymbalta, arguing ahead of a trial scheduled for next week that she "fundamentally misrepresents" the drug's label.

  5. June 09, 2015

    Eli Lilly Pushes To Toss Cymbalta Withdrawal Suits

    Eli Lilly & Co. told a California federal court Monday that plaintiffs in two suits accusing the drugmaker of downplaying the alleged withdrawal effects of its antidepressant Cymbalta had not unearthed any new information about the drug's clinical trials that supports their claims.

  6. April 29, 2015

    Eli Lilly Keeps Employees' Salary Info From Cymbalta Suit

    Eli Lilly & Co. has persuaded a California federal court to keep the salary information of its employee witnesses from a suit over the alleged withdrawal effects of its antidepressant Cymbalta, with a magistrate judge siding with the drugmaker's arguments that such information relating to employees isn't fair game.

  7. April 23, 2015

    Protect Workers' Salary Info In Suit, Cymbalta Maker Says

    Eli Lilly & Co. argued Thursday that its employee witnesses should not be required to disclose their salary information in a suit over the alleged withdrawal effects of its antidepressant Cymbalta, arguing that employees who are asked to testify in such cases can keep the details of their compensation private.